The fourth cohort of an ongoing phase 1/2 has dosed its first patient with TTX-MC138 in advanced solid tumors.

The following is a summary of “Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma ...

RFK Jr., the nation’s new health secretary, has cited “highly chemically processed foods” as a chief culprit behind an ...

Rozanolixizumab is a high-affinity humanized immunoglobulin G4 monoclonal antibody and Fc receptor blocker approved to treat ...

MANILA – Agriculture Secretary Francisco Tiu Laurel Jr. on Monday disclosed the alleged misdeclaration of three-batch imports ...

Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo.

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%.

“Eggs should absolutely be part of your weekly rotation, but you want to eat the egg with the yolk,” says Barmmer. In a large ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

Sensei Biotherapeutics (SNSE) announced initial results from the dose expansion portion of its Phase 1/2 trial evaluating solnerstotug, a ...

Discover why Immutep's Eftilagimod Alpha shows promise in NSCLC and HNSCC trials, but cautious investment is advised. Explore more details here.